Evidence map›Paper›PMID 34365812›Full record

SynthesisHypertension (Dallas, Tex. : 1979)2021

Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium.

Jung-Im Shin, Alex R Chang, Morgan E Grams, Josef Coresh, Shoshana H Ballew, Aditya Surapaneni, Kunihiro Matsushita, Henk J G Bilo, Juan J Carrero, Gabriel Chodick and 12 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Hypertension (Dallas, Tex. : 1979), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 3 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 3 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Adults with hypertension: recommendations for minimum standards rather than optimal monitoring?The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Article
  9. Article
  10. Beyond pressure-centric titration: toward organ-response-guided hypertension management.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  11. Care Processes and Clinical Responses to Newly Detected Albuminuria: The Stockholm Creatinine Measurements (SCREAM) Project.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  12. Review
  13. ERA's ABCDE framework for kidney disease prevention: turning the WHO kidney health resolution into action.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Risk-based referral model to nephrologist specialist care in Stockholm.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Observational

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 5 countries.

Jung-Im ShinFrom the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.-I.S., M.E.G., J.C., S.H.B., A.S., K.M., M.W., Y.S.).
Alex R ChangDepartment of Nephrology and Kidney Health Research Institute, Geisinger Medical Center, Danville, Pennsylvania (A.R.C.).
Morgan E GramsFrom the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.-I.S., M.E.G., J.C., S.H.B., A.S., K.M., M.W., Y.S.).
Josef CoreshFrom the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.-I.S., M.E.G., J.C., S.H.B., A.S., K.M., M.W., Y.S.).ORCID 0000-0002-4598-0669
Shoshana H BallewFrom the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.-I.S., M.E.G., J.C., S.H.B., A.S., K.M., M.W., Y.S.).ORCID 0000-0002-7547-3764
Aditya SurapaneniFrom the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.-I.S., M.E.G., J.C., S.H.B., A.S., K.M., M.W., Y.S.).
Kunihiro MatsushitaFrom the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.-I.S., M.E.G., J.C., S.H.B., A.S., K.M., M.W., Y.S.).
Henk J G BiloDiabetes Centre, Isala, and Department of Internal Medicine (H.J.G.B.), University of Groningen, University Medical Center Groningen, the Netherlands.
Juan J CarreroDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Huddinge, Sweden (J.J.C.).ORCID 0000-0003-4763-2024
Gabriel ChodickMedical Division, Maccabi Healthcare Services, and Sackler Faculty of Medicine, Tel Aviv University, Israel (G.C.).
Kenn B DarathaProvidence St. Joseph Health on behalf of CURE-CKD Investigators, Spokane, WA (K.B.D.).ORCID 0000-0002-9194-4140
Simerjot K JassalDivision of General Internal Medicine, University of California, San Diego and VA San Diego Healthcare, California (S.K.J.).
Girish N NadkarniDepartment of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York (G.N.N.).ORCID 0000-0001-6319-4314
Robert G NelsonNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona (R.G.N.).
Christoph NowakDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden (C.N.).ORCID 0000-0001-8435-3978
Nikita StempniewiczAMGA (American Medical Group Association), Alexandria, Virginia and OptumLabs Visiting Fellow, Eden Prairie, MN (N.S.).
Keiichi SumidaDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN (K.S.).
Jamie P TraynorGlasgow Renal Transplant Unit, Queen Elizabeth University Hospital Glasgow Scotland, United Kingdom (J.P.T.).ORCID 0000-0002-4339-0366
Mark WoodwardFrom the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.-I.S., M.E.G., J.C., S.H.B., A.S., K.M., M.W., Y.S.).ORCID 0000-0001-9800-5296
Yingying SangFrom the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.-I.S., M.E.G., J.C., S.H.B., A.S., K.M., M.W., Y.S.).
Ron T GansevoortDepartment of Nephrology (R.T.G.), University of Groningen, University Medical Center Groningen, the Netherlands.
CKD Prognosis Consortium
Johns Hopkins University · USKarolinska Institutet · SEQueen Elizabeth University Hospital · GBUniversity Medical Center Groningen · NLUniversity of California San Diego · USAmerican Medical Group Association · USGeisinger Medical Center · USIcahn School of Medicine at Mount Sinai · USNational Institutes of Health · USSt. Joseph Health System · USTel Aviv University · ILUniversity of Tennessee Health Science Center · US

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
Chronic Kidney Disease Prognosis Consortium (CKD-PC)R01DK100446 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JOSEF CORESH, Morgan Erika Grams · 2014 to 2026
$10.7M
Epidemiology, Pathophysiology and Treatment of Diabetic NephropathyZIADK069062 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI NELSON, ROBERT G · 2009 to 2023
$10.1M
Medication Use and Adverse Events in CKDR01DK115534 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Alexander R Chang, Morgan Erika Grams · 2018 to 2026
$5.7M
Prevention and Treatment of Cardiovascular Disease in Patients with Chronic Kidney Disease: Patient-Oriented Research and Mentoring - RenewalK24HL155861 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Morgan Erika Grams · 2021 to 2026
$732k
The Comparative Effectiveness and Safety of Second-line Therapy in Patients with Type 2 DiabetesK01DK121825 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SHIN, JUNG-IM · 2019 to 2022
$615k
NHLBI NIH HHS K24 HL155861NIDDK NIH HHS K01 DK121825NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK100446NIDDK NIH HHS R01 DK115534
6 · The paper itself

Abstract

[Figure: see text].

Indexed as

AdultAgedAlbuminuriaCreatinineDiabetes MellitusGlomerular Filtration RateHumansHypertensionMiddle AgedRenal Insufficiency, ChronicCreatininealbuminuriablood pressurediabetes mellitushypertensionkidneyprevalence risk

Identifiers

PMID34365812
PMCPMC8429211
OpenAlexW3188495695

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.